Concept Development Workshop
A New Concept Workshop will be held by BCT at the 46th ASM, to provide an opportunity for BCT members and non-members to present new research ideas. The workshop will involve a presentation of selected concepts, followed by discussion and feedback from the audience. The audience will include BCT Scientific Advisory Committee members, Consumer Advisory Panel representatives, senior BCT staff, and other BCT researchers.
More information including the application closing date will be made available in the upcoming months.
Concepts are welcomed from all disciplines relevant to breast cancer care, including medical, surgical, or radiation oncology, reconstructive surgery, imaging, pathology, and the supportive care disciplines.
Pictured – Attendees in Session at the 2019 ASM in Adelaide
Workshop Details
This workshop is designed to be an opportunity for those with ideas with the potential to become BCT-led clinical trials to present them to the group.
These ideas can potentially move forward to a more formal stage of concept development with the support of BCT’s Scientific Advisory Committee.
Application Information
Submissions are welcome from both BCT members and non-members. However, for all concepts that are approved for ongoing development, applicants must become BCT members. Click the button below to find out more about how to become a member.
- Concept submissions will be peer-reviewed and reviews will be provided to applicants.
- Up to six concepts will be chosen for presentation, with notification in mid/late June 2025.
- BCT will invite a discussant for each presentation.
- Feedback will be provided by BCT following concept presentations at the workshop on 23 July 2025.
Eligibility Criteria
- Fulfills the definition of clinical or translational research that relates to prior, current, or the development of future BCT-led breast cancer clinical trials.
- Potential to make a significant impact on the care of those affected by breast cancer.
- Feasible as research with significant involvement from BCT.
- Potentially eligible for competitive funding e.g. NHMRC or Cancer Councils.
- Presenters will be expected to attend the workshop in person and are responsible for their own travel and accommodation.
Trial Development Process
Click the button below for additional information about the BCT trial development process, or visit the ‘Research’ section of the BCT website if you are a full member. Refer to the ‘Clinical Trials/Investigator Resources’ tab or via the following link Research Development and Funding.
Please note: BCT typically conducts Phase II and Phase III trials. Phase I trials may be considered by BCT where the science has originated from the laboratory of a BCT member, drug supply is available, and there is a clear pathway to Phase II and Phase III trials led by BCT.